InvestorsHub Logo
Followers 36
Posts 2689
Boards Moderated 0
Alias Born 06/09/2011

Re: flipper44 post# 90618

Tuesday, 12/20/2016 11:42:28 AM

Tuesday, December 20, 2016 11:42:28 AM

Post# of 696884
I hope you are right Flip! We all have seen the Linda Liau presentation last week in Seattle and slides supporting the potential for favorable efficacy for DCVax-L.

Management has to come through with some positive news! We knew financing had to be soon and I did not go back and check but was this the financing held up on the 20% rule?

It is unusual that a company is beat down this hard just before phase iii results. Normally, it's just some volatility, with a couple spikes and troughs in the last month or so before results.

Here, everything rests on phase iii results unless BMY or some other combination trial monetarily incentivizes NWBO, but it seems like no final negotiation there either until phase III results. Someone once said it was a dangerous game management was playing, and I guess the same could be said for big pharma.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News